Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management

authors:

avatar Mostafa shafiei 1 , avatar Seyed Moayed Alavian 1 , *

Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Hepatitis Monthly: Vol.12, issue 2; e93033
published online: February 29, 2012
article type: Editorial
received: May 06, 2019
accepted: February 29, 2012
DOI: https://doi.org/10.5812/hepatmon.840

how to cite: shafiei M, Alavian S M. Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management. Hepat Mon. 2012;12(2):e93033. https://doi.org/10.5812/hepatmon.840.

Abstract

Autoimmune hepatitis is a quite serious disease, and will get worse if not treated properly. AIH is a disease that needs to be managed under the supervision of a team of specialists, including at least one hepatologist or a gastroenterologist with an interest in liver disease, as well as a laboratory that can measure all serum autoantibodies with accurate titres. This article is highly recommended to hepatologists, gastroenterologists, virologists, general practitioners, and researchers who are interested in public health.
Please cite this paper as:
Shafiei M, Alavian SM. Autoimmune Hepatitis in Iran: What We Know, What We Don't Know and Requirements for Better Management. Hepat Mon. 2012;12(2):73-6. DOI: 10.5812/hepatmon.840

References

  • 1.

    The references are available in the PDF file.